Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,499.40 +111.83 0.73%
S&P 500 1,679.13 +9.97 0.60%
Nasdaq 3,521.55 +19.43 0.55%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 +13.36 0.47%
FTSE 100 6,840.27 +36.40 0.53%
DAX 8,530.89 +58.69 0.69%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Exchange: London
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

GlaxoSmithKline PLC

+ Add to Watchlist

GSK:LN

1,765.500 GBp 23.500 1.35%

As of 11:27:30 ET on 05/22/2013.

Snapshot for GlaxoSmithKline PLC (GSK)

Open: 1,744.000 Day's Range: 1,734.000 - 1,771.500 Volume: 7,391,655
Previous Close: 1,742.000 52wk Range: 1,314.000 - 1,771.500 1-Yr Rtn: +31.27%

Stock Chart for GSK

No chart data available.
  • GSK:LN 1,773.000
  • 1D
  • 1M
  • 1Y
1,742.000
Interactive GSK Chart

Previous Close

Key Statistics for GSK

Current P/E Ratio (ttm) 20.2986
Estimated P/E(12/2013) 14.9443
Relative P/E vs. UKX 1.2100
Earnings Per Share (GBP) (ttm) 0.8599
Est. EPS (GBP) (12/2013) 1.1680
Est. PEG Ratio 2.1737
Market Cap (M GBP) 86,008.80
Shares Outstanding (M) 4,927.46
30 Day Average Volume 7,611,637
Price/Book (mrq) 11.4742
Price/Sale (ttm) 3.2836
Dividend Indicated Gross Yield 4.77%
Cash Dividend (GBp) 18.0000
Last Dividend 05/08/2013
5 Year Dividend Growth 6.79%
Next Earnings Announcement 07/25/2013
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GSK

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for GSK

GlaxoSmithKline PLC is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart & circulatory disease, and cancer.

Andrew WittyChief Executive OfficerSimon P DingemansChief Financial Officer
David RedfernChief Strategy OfficerMoncef SlaouiChairman:R&D & Vaccines
More Company Profile & Key Executives for GSK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil